Vizient, Inc. Submits Comments to the FDA about Biosimilar...
Dateline City: IRVING, Texas IRVING, Texas--(BUSINESS WIRE)--On May 19, 2017, Vizient, Inc. submitted comments to the Food and Drug Administration (FDA) regarding its notice “Considerations on...
View ArticleVizient Presents on Radiopharmaceutical Trends at 2017 Mo-99 Topical Meeting
Dateline City: IRVING, Texas IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announces Leah Gannon, MBA, senior portfolio executive, pharmacy sourcing operations will present on industry dynamics that...
View ArticleVizient Launches Purchased Services Module for Savings Actualyzer Analytics...
Dateline City: IRVING, Texas IRVING, Texas--(BUSINESS WIRE)--Purchased services generally accounts for more than 20 percent of a hospital’s total annual expenses and includes more than 300 product...
View Article